Velissarios Karacostas
Psychiatry · Cincinnati, OHNPI 1023037926
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $47,513 of the $56,078 with a category attached, or 84.7%. Supernus Pharmaceuticals, Inc. accounts for 95.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $27,940 and has fallen 51.1% since, to $13,669 in 2025. Among psychiatry clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $376.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$54K
- Ironshore Pharmaceuticals Inc.$704
- AbbVie$432
- Axsome Therapeutics, Inc.$342
- Neurocrine Biosciences, Inc.$234
- Teva Pharmaceuticals USA, Inc.$200
- plus $532 from 5 others
What the payments were for
- Speaking & faculty fees$47,51385%
- Travel & lodging$4,0617%
- Food & beverage$4,4578%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 93 | $53,635 |
| Ironshore Pharmaceuticals Inc. | 6 | $704 |
| AbbVie(2 entities) | 18 | $432 |
| Axsome Therapeutics, Inc. | 3 | $342 |
| Neurocrine Biosciences, Inc. | 2 | $234 |
| Teva Pharmaceuticals USA, Inc. | 2 | $200 |
| Sunovion Pharmaceuticals Inc. | 13 | $194 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $187 |
| Johnson & Johnson | 1 | $112 |
| Lundbeck LLC | 1 | $24 |
| Neos Therapeutics, LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$51,326
- Jornay PM 20mg capsules (Bottle of 100)$676
- Auvelity$342
- VRAYLAR$254
- INGREZZA$234
- Austedo XR$121
- SPRAVATO$112
How this compares
$56,078 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 12 | $18,755 |
| Lisdexamfetamine Dimesylate | 16 | $4,022 |
| Divalproex Sodium ErDivalproex Sodium | 24 | $2,840 |
| Propranolol Hcl ErPropranolol Hcl | 13 | $433 |
| Bupropion XlBupropion Hcl | 11 | $344 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 12 | $302 |
| Escitalopram Oxalate | 26 | $296 |
| Duloxetine Hcl | 14 | $268 |
| Methylphenidate Hcl | 21 | $225 |
| Buspirone Hcl | 19 | $194 |
| Propranolol Hcl | 22 | $185 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $119 |
| Metformin Hcl | 21 | $94 |
| Trazodone Hcl | 13 | $86 |
| Lorazepam | 11 | $14 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $187 | $18,75512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Cincinnati
- Henry NasrallahCincinnati$3.8M
- Paul KeckCincinnati$739K
- Tracey SkaleCincinnati$674K
- Helen FarrellCincinnati$277K
- Caleb AdlerCincinnati$143K
- Jeffrey StrawnCincinnati$30K
- John HawkinsCincinnati$30K
- Fred RomeoColumbus$2.3M
- Amita PatelDayton$2.1M
- Pradeep ManudhaneCanton$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.